Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:18423376rdf:typepubmed:Citationlld:pubmed
pubmed-article:18423376lifeskim:mentionsumls-concept:C0208355lld:lifeskim
pubmed-article:18423376lifeskim:mentionsumls-concept:C0035696lld:lifeskim
pubmed-article:18423376lifeskim:mentionsumls-concept:C1514216lld:lifeskim
pubmed-article:18423376lifeskim:mentionsumls-concept:C0599894lld:lifeskim
pubmed-article:18423376lifeskim:mentionsumls-concept:C1521840lld:lifeskim
pubmed-article:18423376lifeskim:mentionsumls-concept:C1511767lld:lifeskim
pubmed-article:18423376pubmed:issue2lld:pubmed
pubmed-article:18423376pubmed:dateCreated2008-5-16lld:pubmed
pubmed-article:18423376pubmed:abstractTextDendritic cells (DCs) transfected with mRNA encoding tumor-associated antigens (TAAs) can induce tumor-specific T-cell responses. To potentiate this, we transfected mature DCs (mDCs) with mRNA encoding TAA targeted to the proteasome. DCs were generated from bone marrow cells by culture with 20 ng/ml GM-CSF and maturation with 1 microg/ml LPS. These mDCs were then electroporated with 10 microg of mRNA. Antigen presentation after electroporation with in vitro transcribed mRNA was compared with mRNA from a construct of the TAA preceded by ubiquitin. Proteasomal targeting of mRNA encoding cotranslationally ubiquitinated antigen was found to enhance intracellular degradation of target protein, and result in more efficient priming and expansion of TAA-specific CD8(+) T-cells. We therefore suggest that RNA-transfected DC vaccine efficacy could be improved by the use of mRNA targeted to the proteasome.lld:pubmed
pubmed-article:18423376pubmed:languageenglld:pubmed
pubmed-article:18423376pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18423376pubmed:citationSubsetIMlld:pubmed
pubmed-article:18423376pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18423376pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18423376pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18423376pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18423376pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18423376pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18423376pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18423376pubmed:statusMEDLINElld:pubmed
pubmed-article:18423376pubmed:monthJunlld:pubmed
pubmed-article:18423376pubmed:issn1090-2104lld:pubmed
pubmed-article:18423376pubmed:authorpubmed-author:MaekawaRyujiRlld:pubmed
pubmed-article:18423376pubmed:authorpubmed-author:KurachiMakoto...lld:pubmed
pubmed-article:18423376pubmed:authorpubmed-author:KakimiKazuhir...lld:pubmed
pubmed-article:18423376pubmed:authorpubmed-author:KimuraKiminor...lld:pubmed
pubmed-article:18423376pubmed:authorpubmed-author:UehaSatoshiSlld:pubmed
pubmed-article:18423376pubmed:authorpubmed-author:TakedaYayoiYlld:pubmed
pubmed-article:18423376pubmed:authorpubmed-author:HosoiAkihiroAlld:pubmed
pubmed-article:18423376pubmed:authorpubmed-author:SakutaKazukoKlld:pubmed
pubmed-article:18423376pubmed:issnTypeElectroniclld:pubmed
pubmed-article:18423376pubmed:day27lld:pubmed
pubmed-article:18423376pubmed:volume371lld:pubmed
pubmed-article:18423376pubmed:ownerNLMlld:pubmed
pubmed-article:18423376pubmed:authorsCompleteYlld:pubmed
pubmed-article:18423376pubmed:pagination242-6lld:pubmed
pubmed-article:18423376pubmed:dateRevised2010-11-18lld:pubmed
pubmed-article:18423376pubmed:meshHeadingpubmed-meshheading:18423376...lld:pubmed
pubmed-article:18423376pubmed:meshHeadingpubmed-meshheading:18423376...lld:pubmed
pubmed-article:18423376pubmed:meshHeadingpubmed-meshheading:18423376...lld:pubmed
pubmed-article:18423376pubmed:meshHeadingpubmed-meshheading:18423376...lld:pubmed
pubmed-article:18423376pubmed:meshHeadingpubmed-meshheading:18423376...lld:pubmed
pubmed-article:18423376pubmed:meshHeadingpubmed-meshheading:18423376...lld:pubmed
pubmed-article:18423376pubmed:meshHeadingpubmed-meshheading:18423376...lld:pubmed
pubmed-article:18423376pubmed:meshHeadingpubmed-meshheading:18423376...lld:pubmed
pubmed-article:18423376pubmed:meshHeadingpubmed-meshheading:18423376...lld:pubmed
pubmed-article:18423376pubmed:meshHeadingpubmed-meshheading:18423376...lld:pubmed
pubmed-article:18423376pubmed:meshHeadingpubmed-meshheading:18423376...lld:pubmed
pubmed-article:18423376pubmed:meshHeadingpubmed-meshheading:18423376...lld:pubmed
pubmed-article:18423376pubmed:meshHeadingpubmed-meshheading:18423376...lld:pubmed
pubmed-article:18423376pubmed:meshHeadingpubmed-meshheading:18423376...lld:pubmed
pubmed-article:18423376pubmed:meshHeadingpubmed-meshheading:18423376...lld:pubmed
pubmed-article:18423376pubmed:meshHeadingpubmed-meshheading:18423376...lld:pubmed
pubmed-article:18423376pubmed:year2008lld:pubmed
pubmed-article:18423376pubmed:articleTitleDendritic cell vaccine with mRNA targeted to the proteasome by polyubiquitination.lld:pubmed
pubmed-article:18423376pubmed:affiliationDepartment of Immunotherapeutics (Medinet), Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-Ku, Tokyo 113-8655, Japan.lld:pubmed
pubmed-article:18423376pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:18423376pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18423376lld:pubmed